Modulation of membrane type 1 matrix metalloproteinase by LPS and gamma interferon bound to extracellular matrix in intestinal crypt cells

Cytokine

Volumn 41, Issue 2, 2008, Pages 155-161

  Alvarado, Jansi ^a   del Castillo, Jesús R ^a   Thomas, Luz E ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Gamma interferon; Intestinal epithelial cell; Lipopolysaccharide; Matrix metalloproteinases; Wound repair

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL STRAIN HT29; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTERFERON PRODUCTION; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE VILLUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

ANIMALS; EXTRACELLULAR MATRIX; HT29 CELLS; HUMANS; INTERFERON TYPE II; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; SUS SCROFA;

BACTERIA (MICROORGANISMS);

EID: 38949106184     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.11.006     Document Type: Article

References (26)

1. Kohler H., Rodrigues S.P., and McCormick B.A. Shigella flexneri interactions with the basolateral membrane domain of polarized model intestinal epithelium: role of lipopolysaccharide in cell invasion and in activation of the mitogen-activated protein kinase ERK. Infect Immun 70 (2002) 1150-1158
2. Backert S., and Konig W. Interplay of bacterial toxins with host defence: molecular mechanisms of immunomodulatory signalling international. J Med Microbiol 295 (2005) 519-530
3. Suzuki M., Hisamatsu T., and Podolsky D.K. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular toll-like receptor 4-MD-2 complex. Infect Immun 71 (2003) 3503-3511
4. Alvarado J., Taylor P., Castillo J.R., and Thomas L. Interferon gamma bound to extracellular matrix changes the hyporesponsiveness to LPS in crypt but not villous intestinal epithelial cells. Immunol Lett 99 (2005) 109-112
5. Autschbach F., Giese T., Gassler N., Sido B., Heuschen G., Heuschen U., et al. Cytokine/chemokine messenger-RNA expression profiles in ulcerative colitis and Crohn's disease. Virchows Arch 441 (2002) 500-513
6. Cario E., and Podolsky D.K. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68 (2000) 7010-7017
7. Camejo E.H., Rosengren B., Camejo G., Sartipy P., Fager G., and Bondjers G. Interferon gamma binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. Arterioscler ThrombVasc Biol 15 (1995) 1456-1465
8. Hurt-Camejo E., Rosengren B., Sartipy P., Elfsberg K., Camejo G., and Svensson L. CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-gamma and some of its biological effects on human vascular smooth muscle cells. J Biol Chem 274 (1999) 18957-18964
9. Lortat-Jacob H., Baltzer F., and Grimaud J.A. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence. J Biol Chem 271 (1996) 16139-16143
10. Ko C.H., Shen S.C., Lee T.J.F., and Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol Cancer Ther 4 (2005) 281-290
11. Murphy G., Knauper V., Cowell S., Hembry R., Stanton H., Butler G., et al. Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci 878 (1999) 25-39
12. Chiba H., Kojima T., Osanai M., and Sawada N. The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease. Sci STKE 316 (2006) pe1
13. Bisping G., Lugering N., Lutke-Brintrup S., Pauels H.G., Schurmann G., Domschke W., et al. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol 123 (2001) 15-22
14. Stallmach A., Giese T., Schmidt C., Ludwig B., Mueller-Molaian I., and Meuer S.C. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis 19 (2004) 308-315
15. Watson C.J., Hoare C.J., Garrod D.R., Carlson G.L., and Warhurst G. Interferon-{gamma} selectively increases epithelial permeability to large molecules by activating different populations of paracellular pores. J Cell Sci 118 (2005) 5221-5230
16. Clark E., Hoare C., Tanianis-Hughes J., Carlson G.L., and Warhurst G. Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 128 (2005) 1258-1267
17. Cetin S., Ford H.R., Sysko L.R., Agarwal C., Wang J., Neal M.D., et al. Endotoxin inhibits intestinal epithelial restitution through activation of Rho-GTPase and increased focal adhesions. J Biol Chem 279 (2004) 24592-24600
18. Suzuki M., Hisamatsu T., and Podolsky D.K. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular toll-like receptor 4-MD-2 complex. Infect Immun 71 (2003) 3503-3511
19. Seiki M. The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 14 (2002) 624-632
20. Chavez A.M., Morin M.J., Unno N., Fink M.P., and Hodin R.A. Acquired interferon gamma responsiveness during Caco-2 cell differentiation: effects on iNOS gene expression. Gut 44 (1999) 659-665
21. Osenkowski P., Toth M., and Fridman R. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol 200 (2004) 2-10
22. Itoh Y., Takamura A., Ito N., Maru Y., Sato H., Suenaga N., et al. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20 (2001) 4782-4793
23. Stanton H., Gavrilovic J., Atkinson S.J., d'Ortho M.P., Yamada K.M., Zardi L., et al. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci 111 (1998) 2789-2798
24. Lehti K., Lohi J., Juntunen M.M., Pei D., and Keski-Oja J. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem 277 (2002) 8440-8448
25. Jiang A., Lehti K., Wang X., Weiss S.J., Keski-Oja J., and Pei D. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 98 (2001) 13693-13698
26. Corbel M., Theret N., Caulet-Maugendre S., Germain N., Lagente V., Clement B., et al. Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm Res 50 (2001) 129-135